FPÖ – Hauser: "EU Commission Pumps 73.7 Million Euros Into Next Experimental mRNA Vaccination
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.2 Articles
2 Articles
In August, the start of the phase one study of Moderna's mRNA gene therapy against the Bundibugyo ebola virus was reported. The EU Commission considers the risk of the virus to the European Union to be very low, but this does not change the fact that European taxpayers are allowed to co-finance the new experimental vaccines.
"While the Commission considers the overall risk of Bundibugyo ebola virus for the EU itself to be very low in response to my parliamentary question, at the same time millions of European taxpayers are being allocated to the development of new experimental vaccines," criticises free MEP Gerald Hauser (request reply: www.europarl.europa.eu/doceo/document/E-10-2026-002409-ASW_DE.pdf).
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
![[Opinion] Κεμπέκ: Πολιτικός «σεισμός» προ των πυλών καθώς η επαρχία οδεύει προς τις κάλπες](/_next/image?url=https%3A%2F%2Fgrnd.b-cdn.net%2Finterests%2F77552585ba37f97befdabee804828c0b3794ab94.jpg&w=1440&q=75)
